August 13, 2014 / 4:33 AM / 3 years ago

Sun Pharma gains after earnings beat estimates

Reuters Market Eye - Sun Pharmaceutical Industries (SUN.NS) gains 1.6 percent after June-quarter earnings beat estimates on higher U.S. sales.

Sequential rise of 20 percent in U.S. sales is a positive surprise, analysts say.

Reporting by Abhishek Vishnoi

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below